Amengual Vila, J.; Sampol Bas, C.M.; Quintero Duarte, A.; Ugarteburu Pérez, A.; Ruiz Coll, M.; Rioja Merlo, J.; Torrent Colomer, A.
Hybrid 99mTc–ICG Sentinel Lymph Node Mapping in Apparent Early-Stage Epithelial Ovarian Cancer: A First Prospective Evaluation of a True Molecular Hybrid Tracer (HibrOv Trial). Cancers 2026, 18, 1973.
https://doi.org/10.3390/cancers18121973
AMA Style
Amengual Vila J, Sampol Bas CM, Quintero Duarte A, Ugarteburu Pérez A, Ruiz Coll M, Rioja Merlo J, Torrent Colomer A.
Hybrid 99mTc–ICG Sentinel Lymph Node Mapping in Apparent Early-Stage Epithelial Ovarian Cancer: A First Prospective Evaluation of a True Molecular Hybrid Tracer (HibrOv Trial). Cancers. 2026; 18(12):1973.
https://doi.org/10.3390/cancers18121973
Chicago/Turabian Style
Amengual Vila, Joana, Catalina Maria Sampol Bas, Adriana Quintero Duarte, Ane Ugarteburu Pérez, Mario Ruiz Coll, Jorge Rioja Merlo, and Anna Torrent Colomer.
2026. "Hybrid 99mTc–ICG Sentinel Lymph Node Mapping in Apparent Early-Stage Epithelial Ovarian Cancer: A First Prospective Evaluation of a True Molecular Hybrid Tracer (HibrOv Trial)" Cancers 18, no. 12: 1973.
https://doi.org/10.3390/cancers18121973
APA Style
Amengual Vila, J., Sampol Bas, C. M., Quintero Duarte, A., Ugarteburu Pérez, A., Ruiz Coll, M., Rioja Merlo, J., & Torrent Colomer, A.
(2026). Hybrid 99mTc–ICG Sentinel Lymph Node Mapping in Apparent Early-Stage Epithelial Ovarian Cancer: A First Prospective Evaluation of a True Molecular Hybrid Tracer (HibrOv Trial). Cancers, 18(12), 1973.
https://doi.org/10.3390/cancers18121973
